Chorokbaem Healthcare Co Ltd (118000) - Total Liabilities

Latest as of March 2026: ₩66.98 Billion KRW ≈ $45.39 Million USD

Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has total liabilities worth ₩66.98 Billion KRW (≈ $45.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Chorokbaem Healthcare Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Chorokbaem Healthcare Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Chorokbaem Healthcare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 118000 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Chorokbaem Healthcare Co Ltd Competitors by Total Liabilities

The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Jaycorp Bhd
KLSE:7152
Malaysia RM54.28 Million
Mgenplus Co. Ltd.
KQ:032790
Korea ₩26.89 Billion
Richmond Vanadium Technology Ltd
AU:RVT
Australia AU$1.20 Million
Biovica International AB (publ)
ST:BIOVIC-B
Sweden Skr31.14 Million
Artroniq Berhad
KLSE:0038
Malaysia RM5.88 Million
Kamdhenu Ventures Limited
NSE:KAMOPAINTS
India Rs1.11 Billion
Geratherm Medical AG
XETRA:GME
Germany €6.95 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Chorokbaem Healthcare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Chorokbaem Healthcare Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.32 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.56 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chorokbaem Healthcare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual total liabilities of Chorokbaem Healthcare Co Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 ₩76.98 Billion
≈ $52.17 Million
+87.67%
2024-12-31 ₩41.02 Billion
≈ $27.80 Million
+133.08%
2023-12-31 ₩17.60 Billion
≈ $11.93 Million
-70.80%
2022-12-31 ₩60.28 Billion
≈ $40.85 Million
+5.93%
2021-12-31 ₩56.90 Billion
≈ $38.56 Million
-8.47%
2020-12-31 ₩62.17 Billion
≈ $42.13 Million
+83.55%
2019-12-31 ₩33.87 Billion
≈ $22.95 Million
-21.10%
2018-12-31 ₩42.93 Billion
≈ $29.09 Million
+138.07%
2017-12-31 ₩18.03 Billion
≈ $12.22 Million
+17.03%
2016-12-31 ₩15.41 Billion
≈ $10.44 Million
+50.77%
2015-12-31 ₩10.22 Billion
≈ $6.93 Million
-10.02%
2014-12-31 ₩11.36 Billion
≈ $7.70 Million
+91.74%
2013-12-31 ₩5.92 Billion
≈ $4.01 Million
--

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General
Market Cap
$16.37 Million
₩24.15 Billion KRW
Market Cap Rank
#25749 Global
#1916 in Korea
Share Price
₩1406.00
Change (1 day)
+4.69%
52-Week Range
₩222.00 - ₩2080.00
All Time High
₩13800.00
About

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more